Replies to post #215762 on Biotech Values

[Bickema]

Jbog in my research, I found that the biggest difference was that dysport diffuses more which I interpret as having a shorter effect on the intended target and a greater chance of adverse effects like droopy eyes or when administered for cervical dystonia troubles in the throat such as swallowing.

But what stands out the most from what I've read is that WHO injects you is much more important than WHAT you are injected with.

[LongRun8]

Dysport
I feel like this was an unfortunate choice for a name. While I'm guessing it was named for the fact it treats cervical dystonia, I can't help but cringe when I hear the name. "Dys" means "bad, ill, or abnormal." Patients probably don't routinely know that, but as a provider, I would tend to have a negative connotation to it. Botox just sounds so much better. They would have been better off if the FDA let them name it Reloxin.

Hopefully, Revance will come up with much better name for their toxin. I like BetterTox or BestTox...haha. I know some people don't think AGN would ever acquire RVNC; but, if they did, I like Botox 2.0 (second generation, works twice as long, and still maintains its major branding).